Paper39337047
Overall Survival and Cancer-Specific Mortality in Patients with Prostate Cancer Undergoing Definitive Therapies: A Narrative Review.
Kawase M and 7 others. J Clin Med, 2024. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Overall Survival and Cancer-Specific Mortality in Patients with Prostate Cancer Undergoing Definitive Therapies: A Narrative Review. Papers, record 39337047. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39337047
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Overall Survival and Cancer-Specific Mortality in Patients with Prostate Cancer Undergoing Definitive Therapies: A Narrative Review.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References101
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28823634 | Ten-year Mortality in Men With Nonmetastatic Prostate Cancer in Norway. | Urology | 2017 | https://conductscience.org/library/papers/28823634 | PubMed |
| 2 | 38493901 | A Randomized Trial Comparing Quality of Life After Low-Dose Rate or High-Dose Rate Prostate Brachytherapy Boost With Pelvic External Beam Radiation Therapy. | Int J Radiat Oncol Biol Phys | 2024 | https://conductscience.org/library/papers/38493901 | PubMed |
| 3 | 37639648 | Biochemical Recurrence Surrogacy for Clinical Outcomes After Radiotherapy for Adenocarcinoma of the Prostate. | J Clin Oncol | 2023 | https://conductscience.org/library/papers/37639648 | PubMed |
| 4 | 38454625 | Efficacy and safety of combination neoadjuvant chemo-hormonal therapy and robot-assisted radical prostatectomy for oligometastatic prostate cancer. | Int J Urol | 2024 | https://conductscience.org/library/papers/38454625 | PubMed |
| 5 | 37627078 | Prognostic Factors for Resolution Delay of Lower Urinary Tract Symptoms in Patients with Prostate Cancer after Low-Dose-Rate Brachytherapy. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37627078 | PubMed |
| 6 | 36171482 | Natural history, and impact of surgery and radiation on survival outcomes of men diagnosed with low-grade prostate cancer at ≤ 55 years of age: a 25-year follow-up of > 60,000 men. | Int Urol Nephrol | 2023 | https://conductscience.org/library/papers/36171482 | PubMed |
| 7 | 28376606 | Positive surgical margin in robot-assisted radical prostatectomy: correlation with pathology findings and risk of biochemical recurrence. | Minerva Urol Nefrol | 2017 | https://conductscience.org/library/papers/28376606 | PubMed |
| 8 | 36894488 | Effect of Prior Local Therapy on Response to First-line Androgen Receptor Axis Targeted Therapy in Metastatic Castrate-resistant Prostate Cancer: A Secondary Analysis of the COU-AA-302 Trial. | Eur Urol | 2023 | https://conductscience.org/library/papers/36894488 | PubMed |
| 9 | 38087327 | Perioperative, function, and positive surgical margin in extraperitoneal versus transperitoneal single port robot-assisted radical prostatectomy: a systematic review and meta-analysis. | World J Surg Oncol | 2023 | https://conductscience.org/library/papers/38087327 | PubMed |
| 10 | 20529522 | Intraoperative management of robotic-assisted versus open radical prostatectomy. | JSLS | 2010 | https://conductscience.org/library/papers/20529522 | PubMed |
| 11 | 32527134 | Effect on survival of local treatment in patients with low prostate-specific antigen, high Gleason score prostate cancer: a population-based propensity score-matched analysis. | Ann Palliat Med | 2020 | https://conductscience.org/library/papers/32527134 | PubMed |
| 12 | 23932439 | Positive surgical margins after radical prostatectomy: a systematic review and contemporary update. | Eur Urol | 2014 | https://conductscience.org/library/papers/23932439 | PubMed |
| 13 | 32497131 | Comparison of perioperative outcomes in elderly (age ≧ 75 years) vs. younger men undergoing robot-assisted radical prostatectomy. | PLoS One | 2020 | https://conductscience.org/library/papers/32497131 | PubMed |
| 14 | 25601341 | Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study. | Lancet Oncol | 2015 | https://conductscience.org/library/papers/25601341 | PubMed |
| 15 | 28262473 | Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer. | Int J Radiat Oncol Biol Phys | 2017 | https://conductscience.org/library/papers/28262473 | PubMed |
| 16 | 35411637 | Impact of nerve sparing in robot-assisted radical prostatectomy on the risk of positive surgical margin and biochemical recurrence. | Int J Urol | 2022 | https://conductscience.org/library/papers/35411637 | PubMed |
| 17 | 31084438 | The correlation between metastasis-free survival and overall survival in non-metastatic castration resistant prostate cancer patients from the Medical Data Vision claims database in Japan. | Curr Med Res Opin | 2019 | https://conductscience.org/library/papers/31084438 | PubMed |
| 18 | 35864293 | Propensity score matching analysis comparing radical prostatectomy and radiotherapy with androgen deprivation therapy in locally advanced prostate cancer. | Sci Rep | 2022 | https://conductscience.org/library/papers/35864293 | PubMed |
| 19 | 33011207 | Randomised trial of external-beam radiotherapy alone or with high-dose-rate brachytherapy for prostate cancer: Mature 12-year results. | Radiother Oncol | 2021 | https://conductscience.org/library/papers/33011207 | PubMed |
| 20 | 28190748 | Modified frailty index associated with Clavien-Dindo IV complications in robot-assisted radical prostatectomies: A retrospective study. | Urol Oncol | 2017 | https://conductscience.org/library/papers/28190748 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42471494 | Expert consensus recommendations for the management of biochemical recurrence in prostate cancer: a Delphi study across clinical scenarios. | Clin Transl Oncol | 2026 | https://conductscience.org/library/papers/42471494 | PubMed |
| 41626698 | Prognostic Factors of Castration-Resistant Prostate Cancer Among Patients With Localized Prostate Cancer Who Underwent Robot-Assisted Radical Prostatectomy in a Retrospective Multicenter Japanese Cohort (MSUG94). | Int J Urol | 2026 | https://conductscience.org/library/papers/41626698 | PubMed |
| 40141762 | Technical Modifications Employed in RARP to Improve Early Continence Recovery: A Literature Review. | Life (Basel) | 2025 | https://conductscience.org/library/papers/40141762 | PubMed |
| 39974814 | Pathologic characteristics and management strategies for two categories of prostate cancer patients with low prostate-specific antigen undergoing radical prostatectomy. | Transl Androl Urol | 2025 | https://conductscience.org/library/papers/39974814 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39337047
GET https://conductscience.org/api/papers/v1/39337047/references?page=2